We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGTX icon
5601
TG Therapeutics
TGTX
$7.46B
$937K ﹤0.01%
108,324
+70,349
+185% +$532K
CEQP
5602
PUT
DELISTED
Crestwood Equity Partners LP
CEQP
$937K ﹤0.01%
26,200
+11,800
+82% +$422K
CNCE
5603
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$937K ﹤0.01%
78,113
+34,582
+79% +$372K
ORBC
5604
DELISTED
ORBCOMM, Inc.
ORBC
$937K ﹤0.01%
129,318
-126,451
-49% -$900K
PPTY
5605
US Diversified Real Estate ETF
PPTY
$25.5M
$936K ﹤0.01%
30,440
+12,974
+74% +$396K
CM icon
5606
CALL
Canadian Imperial Bank of Commerce
CM
$113B
$935K ﹤0.01%
23,800
+16,400
+222% +$661K
IEX icon
5607
IDEX
IEX
$17.6B
$935K ﹤0.01%
5,434
-208
-4% -$32.7K
FRO icon
5608
CALL
Frontline
FRO
$9.17B
$934K ﹤0.01%
116,700
-15,800
-12% -$126K
CIZ
5609
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
$934K ﹤0.01%
29,124
+4,605
+19% +$146K
BIB icon
5610
PUT
ProShares Ultra NASDAQ Biotechnology
BIB
$86.6M
$933K ﹤0.01%
18,000
+13,500
+300% +$672K
AFIF icon
5611
Anfield Universal Fixed Income ETF
AFIF
$228M
$932K ﹤0.01%
94,480
+2,313
+3% +$23K
REGI
5612
DELISTED
Renewable Energy Group, Inc.
REGI
$931K ﹤0.01%
58,709
-250,568
-81% -$4.62M
AGGP
5613
DELISTED
IQ Enhanced Core Plus Bond U.S. ETF
AGGP
$930K ﹤0.01%
47,710
-3,594
-7% -$69.2K
HAIN icon
5614
PUT
Hain Celestial
HAIN
$52.4M
$929K ﹤0.01%
42,400
-17,000
-29% -$373K
DTIL icon
5615
Precision BioSciences
DTIL
$205M
$926K ﹤0.01%
2,330
+720
+45% +$290K
WW
5616
DELISTED
WW International
WW
$926K ﹤0.01%
48,457
-172,714
-78% -$3.42M
NULG icon
5617
Nuveen ESG Large-Cap Growth ETF
NULG
$2.8B
$925K ﹤0.01%
24,881
-3,362
-12% -$121K
SIL icon
5618
CALL
Global X Silver Miners ETF NEW
SIL
$4.79B
$925K ﹤0.01%
34,500
-6,700
-16% -$164K
SNBR
5619
CALL
DELISTED
Sleep Number
SNBR
$925K ﹤0.01%
22,900
-64,500
-74% -$2.49M
DWTR
5620
DELISTED
Invesco DWA Tactical Sector Rotation ETF
DWTR
$925K ﹤0.01%
29,742
+14,658
+97% +$441K
ACIU icon
5621
AC Immune
ACIU
$248M
$924K ﹤0.01%
166,427
+42,414
+34% +$216K
BNS icon
5622
PUT
Scotiabank
BNS
$112B
$924K ﹤0.01%
17,000
-2,200
-11% -$118K
JPIB icon
5623
JPMorgan International Bond Opportunities ETF
JPIB
$2.13B
$923K ﹤0.01%
18,234
+53
+0.3% +$2.63K
NEWT icon
5624
NewtekOne
NEWT
$376M
$923K ﹤0.01%
40,133
-19,790
-33% -$432K
XPP icon
5625
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.31M
$923K ﹤0.01%
13,850
-158
-1% -$10.5K

Similar funds

Citadel Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
  • Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.